Analyte Specific Reagent. Analytical and performance characteristics are not established.
- Clone
- DX22
- Other Names
- KP43
- Isotype
- Mouse IgG1, κ
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
981104 | 500 µL | 200€ |
CD94 is a 43 kD type II transmembrane glycoprotein also known as KP43. CD94 belongs to the C-type lectin superfamily and is present as a covalently linked heterodimer with NKG2 on the cell surface. CD94 is expressed by NK cells, a subset of γδ T cells, and NKT cells. The CD94/NKG2A complex serves as an inhibitory receptor specific for HLA-class I molecules.
Product DetailsProduct Details
- Reactivity
- Human
- Formulation
- Phosphate-buffered solution, pH 7.2, 0.09% sodium azide, 0.2% (w/v) BSA (origin USA), and a stabilizer.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions.
- Concentration
- 100 µg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
Suggested for Flow Cytometry
- Disclaimer
-
WARNINGS AND PRECAUTIONS
- Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet.
- This antibody contains sodium azide. Follow federal, state and local regulations to dispose of this reagent. Sodium azide build-up in metal wastepipes may lead to explosive conditions; if disposing of reagent down wastepipes, flush with water after disposal.
- All specimens, samples and any material coming in contact with them should be considered potentially infectious and should be disposed of with proper precautions and in accordance with federal, state and local regulations.
- Do not use this reagent beyond the expiration date stated on the label.
- Do not use this reagent if it appears cloudy or if there is any change in the appearance of the reagent as these may be an indication of possible deterioration.
- Avoid prolonged exposure of the reagent or stained cells to light.
Antigen Details
- Antigen References
-
- Lopez-Botet M, et al. 1997. Immunol Rev. 155:165-74.
- Moretta A, et al. 1997. Immunol Rev. 155:105-17.
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
APC anti-human CD94
Human peripheral blood lymphocytes stained with DX22 APC -
FITC anti-human CD94
Human peripheral blood lymphocytes stained with DX22 FITC -
PE anti-human CD94
Human peripheral blood lymphocytes stained with DX22 PE Confocal image of human lymph node sample acquired using the... -
Purified anti-human CD94
Human peripheral blood lymphocytes stained with purified DX2... -
Alexa Fluor® 647 anti-human CD94
Human peripheral blood lymphocytes stained with DX22 Alexa F... -
PerCP/Cyanine5.5 anti-human CD94
Human peripheral blood lymphocytes were stained with CD94 (c... -
PE/Cyanine7 anti-human CD94
Human peripheral blood lymphocytes were stained with CD94 (c... -
APC/Fire™ 750 anti-human CD94
Human peripheral blood lymphocytes were stained with CD94 (c... -
PE/Dazzle™ 594 anti-human CD94
Human peripheral blood lymphocytes were stained with CD94 (c... -
TotalSeq™-A0867 anti-human CD94
-
TotalSeq™-C0867 anti-human CD94
-
PE/Fire™ 810 anti-human CD94
Human peripheral blood lymphocytes were stained with anti-hu... -
TotalSeq™-B0867 anti-human CD94
-
TotalSeq™-D0867 anti-human CD94
-
APC anti-human CD94
Typical results from human peripheral blood lymphocytes stai... -
APC/Cyanine7 anti-human CD94
Human peripheral blood lymphocytes were stained with anti-hu... -
FITC anti-human CD94
Typical results from human peripheral blood lymphocytes stai... -
GMP APC anti-human CD94
Typical results from human peripheral blood lymphocytes stai...
Follow Us